Recommendations for the multidisciplinary management of tuberous sclerosis complex

[1]  D. Krueger,et al.  Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis , 2015, Annals of neurology.

[2]  P. J. Vries,et al.  Neurological and neuropsychiatric aspects of tuberous sclerosis complex , 2015, The Lancet Neurology.

[3]  R. Hinton,et al.  Cardiovascular Manifestations of Tuberous Sclerosis Complex and Summary of the Revised Diagnostic Criteria and Surveillance and Management Recommendations From the International Tuberous Sclerosis Consensus Group , 2014, Journal of the American Heart Association.

[4]  M. Wataya-Kaneda,et al.  Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements. , 2014, JAMA dermatology.

[5]  H. Chugani,et al.  Transition into adulthood: Tuberous sclerosis complex, Sturge‐Weber syndrome, and Rasmussen encephalitis , 2014, Epilepsia.

[6]  E. Thiele,et al.  Intracranial Arteriopathy in Tuberous Sclerosis Complex , 2014, Journal of child neurology.

[7]  À. Rovira,et al.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex , 2014, Journal of Neuro-Oncology.

[8]  A. Wilfong,et al.  Treating Epilepsy in Tuberous Sclerosis with Everolimus: Getting Closer , 2014, Epilepsy currents.

[9]  D. Franz.  Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex , 2013, Biologics : targets & therapy.

[10]  Hope Northrup,et al.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. , 2013, Pediatric neurology.

[11]  D. Krueger,et al.  Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference , 2013, Pediatric neurology.

[12]  Jian-Guo Zhang,et al.  Predictors of seizure freedom after surgical management of tuberous sclerosis complex: A systematic review and meta-analysis , 2013, Epilepsy Research.

[13]  David Chen,et al.  Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial , 2013, The Lancet.

[14]  D. Krueger,et al.  Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma , 2013, Neurology.

[15]  E. Thiele,et al.  Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial , 2013, The Lancet.

[16]  C. Sternberg,et al.  Targeted therapies for renal cell carcinoma: review of adverse event management strategies. , 2012, Journal of the National Cancer Institute.

[17]  A. Goldstein,et al.  Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population , 2011, Journal of Medical Genetics.

[18]  W. Linehan,et al.  Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. , 2010, Chest.

[19]  A. Dwyer,et al.  CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis. , 2010, Radiology.

[20]  J. Ancochea,et al.  Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry. , 2009, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[21]  A. Geha,et al.  The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  H. Shimizu.  Our Experience with Pediatric Epilepsy Surgery Focusing on Corpus Callosotomy and Hemispherotomy , 2005, Epilepsia.

[23]  H. Northrup,et al.  Germ-line mosaicism in tuberous sclerosis: how common? , 1999, American journal of human genetics.

[24]  N. Silverman,et al.  Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports. , 1995, Journal of the American College of Cardiology.

[25]  J. Hughes,et al.  Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome , 1994, Nature Genetics.

[26]  S. Segal,et al.  Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  B. King,et al.  Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. , 2015, Pediatric neurology.

[28]  C. Shields,et al.  Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex. , 2004, Transactions of the American Ophthalmological Society.